OrPro Therapeutics, Inc. is a San Diego preclinical-stage Johnson & Johnson JLABS alumni company addressing large unmet medical needs in acute and chronic respiratory, ophthalmology, and oncology with a cell-protective biologic drug platform based on the secreted human protein thioredoxin. Lead asset ORP100S has been shown to reduce inflammation, normalize mucociliary functions, and mitigate adverse effects of chemotherapy and radiation on stem cells in bone marrow and other sensitive organs through a novel covalent-binding mechanism that opens up disease-modifying treatment opportunities in obstructive, oxidative and inflammatory disorders, vision-threatening diseases of the retina, and cancer therapy.
View Top Employees from Orpro Therapeutics| Website | http://orprotherapeutics.com |
| Revenue | $3 million |
| Employees | 3 (1 on RocketReach) |
| Founded | 2006 |
| Address | 3210 Merryfield Row, San Diego, California 92121, US |
| Phone | (858) 242-1557 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care, Therapeutics |
| Competitors | Cantabio Pharmaceuticals, Inc., Matinas BioPharma, Moerae Matrix, Inc., The Column Group |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Orpro Therapeutics employee's phone or email?
Orpro Therapeutics Questions
The Orpro Therapeutics annual revenue was $3 million in 2024.
1 people are employed at Orpro Therapeutics.
Orpro Therapeutics is based in San Diego, California.
The NAICS codes for Orpro Therapeutics are [541714, 54, 541, 5417, 54171].
The SIC codes for Orpro Therapeutics are [87, 873].
Top Orpro Therapeutics Employees
Related Companies
